139 related articles for article (PubMed ID: 8111819)
1. Cimetidine QID and BID in rapid heartburn relief and healing of lesions in gastroesophageal reflux disease.
Palmer RH; Miller DM; Hedrich DA; Karlstadt RG
Clin Ther; 1993; 15(6):994-1001. PubMed ID: 8111819
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of cimetidine and ranitidine in the pain relief and acute healing of duodenal ulcer disease.
Young MD; Lottes SR; Webb LA
Clin Ther; 1988; 10(5):543-52. PubMed ID: 2856597
[TBL] [Abstract][Full Text] [Related]
3. Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study. USA Merck Gastroesophageal Reflux Disease Study Group.
Sabesin SM; Berlin RG; Humphries TJ; Bradstreet DC; Walton-Bowen KL; Zaidi S
Arch Intern Med; 1991 Dec; 151(12):2394-400. PubMed ID: 1746996
[TBL] [Abstract][Full Text] [Related]
4. Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial.
Behar J; Brand DL; Brown FC; Castell DO; Cohen S; Crossley RJ; Pope CE; Winans CS
Gastroenterology; 1978 Feb; 74(2 Pt 2):441-8. PubMed ID: 340333
[TBL] [Abstract][Full Text] [Related]
5. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
Rush DR; Stelmach WJ; Young TL; Kirchdoerfer LJ; Scott-Lennox J; Holverson HE; Sabesin SM; Nicholas TA
J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452
[TBL] [Abstract][Full Text] [Related]
6. Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group.
Castell DO; Sigmund C; Patterson D; Lambert R; Hasner D; Clyde C; Zeldis JB
Am J Gastroenterol; 1998 Apr; 93(4):547-52. PubMed ID: 9576446
[TBL] [Abstract][Full Text] [Related]
7. Nizatidine versus placebo in gastroesophageal reflux disease: a 12-week, multicenter, randomized, double-blind study.
Cloud ML; Offen WW; Robinson M
Am J Gastroenterol; 1991 Dec; 86(12):1735-42. PubMed ID: 1962618
[TBL] [Abstract][Full Text] [Related]
8. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
Haag S; Holtmann G
Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
[TBL] [Abstract][Full Text] [Related]
9. Cimetidine 800 mg twice daily for healing erosions and ulcers in gastroesophageal reflux disease.
Palmer RH; Frank WO; Rockhold FW; Wetherington JD; Young MD
J Clin Gastroenterol; 1990; 12 Suppl 2():S29-34. PubMed ID: 2246493
[TBL] [Abstract][Full Text] [Related]
10. Cimetidine therapy for gastroesophageal reflux disease.
Archambault AP; Farley A; Cleator IG; Hershfield NB; Navert H; Prokipchuk EJ; Thomson AB
West J Med; 1985 Nov; 143(5):616-21. PubMed ID: 3909640
[TBL] [Abstract][Full Text] [Related]
11. Nizatidine versus placebo in gastro-oesophageal reflux disease: a 6-week, multicentre, randomised, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group.
Cloud ML; Offen WW
Br J Clin Pract Suppl; 1994 Nov; 76():11-9. PubMed ID: 7794700
[TBL] [Abstract][Full Text] [Related]
12. Nizatidine versus placebo in gastro-oesophageal reflux disease: a 12-week, multicentre, randomised, double-blind study.
Cloud ML; Offen WW; Robinson M
Br J Clin Pract Suppl; 1994 Nov; 76():3-10. PubMed ID: 7794701
[TBL] [Abstract][Full Text] [Related]
13. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
Johnson DA; Orr WC; Crawley JA; Traxler B; McCullough J; Brown KA; Roth T
Am J Gastroenterol; 2005 Sep; 100(9):1914-22. PubMed ID: 16128933
[TBL] [Abstract][Full Text] [Related]
14. Ranitidine versus cimetidine in the healing of erosive esophagitis.
McCarty-Dawson D; Sue SO; Morrill B; Murdock RH
Clin Ther; 1996; 18(6):1150-60. PubMed ID: 9001831
[TBL] [Abstract][Full Text] [Related]
15. Sucralfate used as adjunctive therapy in patients with severe erosive peptic esophagitis resulting from gastroesophageal reflux.
Herrera JL; Shay SS; McCabe M; Peura DA; Johnson LF
Am J Gastroenterol; 1990 Oct; 85(10):1335-8. PubMed ID: 2220725
[TBL] [Abstract][Full Text] [Related]
16. Low-dose antacids versus 400 mg cimetidine twice daily for reflux oesophagitis. A comparative, placebo-controlled, multicentre study.
Farup PG; Weberg R; Berstad A; Wetterhus S; Dahlberg O; Dybdahl J; Fyllingen G; Kannelønning KS; Lange OJ
Scand J Gastroenterol; 1990 Mar; 25(3):315-20. PubMed ID: 2181623
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy.
Larson JD; Patatanian E; Miner PB; Rayburn WF; Robinson MG
Obstet Gynecol; 1997 Jul; 90(1):83-7. PubMed ID: 9207819
[TBL] [Abstract][Full Text] [Related]
18. Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a double-blind trial.
McCallum RW; Fink SM; Winnan GR; Avella J; Callachan C
Am J Gastroenterol; 1984 Mar; 79(3):165-72. PubMed ID: 6367434
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non-erosive reflux disease.
Fass R; Chey WD; Zakko SF; Andhivarothai N; Palmer RN; Perez MC; Atkinson SN
Aliment Pharmacol Ther; 2009 Jun; 29(12):1261-72. PubMed ID: 19392864
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial: maintenance intermittent therapy with rabeprazole 20 mg in patients with symptomatic gastro-oesophageal reflux disease - a double-blind, placebo-controlled, randomized study.
Fass R; Delemos B; Nazareno L; Kao R; Xiang J; Lu Y
Aliment Pharmacol Ther; 2010 May; 31(9):950-60. PubMed ID: 20132154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]